
Hyperliquid Strategies Moves Closer to $1B Equity Deal After Sonnet BioTherapeutics Merger Filing
Hyperliquid Strategies Inc., a Delaware-based company, has taken a significant step toward expansion through a detailed Business Combination Agreement. The agreement involves Sonnet BioTherapeutics Holdings Inc., Rorschach I LLC, and








